Choroideremia Research
Choroideremia natural history studies
We are enrolling qualified patients with choroideremia in order to measure disease progression in a group of patients with this disease.
Choroideremia gene therapy trials
Qualifying patients may enter a gene therapy trial in an attempt to slow or halt the progression of Choroideremia
In order to be seen at the Retina Foundation of the Southwest, you must have a referral from your ophthalmologist.
If you have a question related to choroideremia, please contact us at 214-363-3911.
![Choroideremia Research Choroideremia Research](https://retinafoundation.org/wp-content/uploads/2018/09/Choroideremia-e1537547364422.jpg)
Related Articles
Gene Therapy Trial at the Retina Foundation of the Southwest featured in The Dallas Morning News Fogg Charitable Trust Awards $50,000 Grant to the Retina Foundation iPad Games Could Be the Future Lazy Eye Treatment Recently@Retina Newsletter February 2024 Phase III Treatment Trial for Stargardt Disease Enrolls First Patient